Results 161 to 170 of about 25,462 (288)

Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study [PDF]

, 2006
BEERMAN I, BELLERI R, F. SCOLARI, FORAMITTI M, GHARAVI A, GUERINI S, IZZI C, LEONE L, LIFTON R, MOVILLI E, PRATI E, REMEDIO A, SANNA-CHERCHI S, TARDANICO R, VIOLA BF   +14 more
core   +1 more source

Plasmatic Profiling of Individuals With Combinations of Type 2 Diabetes Mellitus, Dyslipidemia and Periodontitis: A Cross‐Sectional Study

Oral Diseases, EarlyView.
ABSTRACT Aim The objective of this study was to investigate the global profile of plasmatic proteins of individuals affected simultaneously or not by type 2 diabetes mellitus (T2DM, well/poorly‐controlled), Dyslipidemia (DL), and Periodontitis (P). Methods Besides periodontal examination, plasma was collected for glycemic, and lipid analyses from 150 ...
François Isnaldo Dias Caldeira, Sâmia Cruz Tfaile Corbi, Alliny de Souza Bastos, Silvana Regina Perez Orrico, Cristiane Ribeiro Salmon, Yizhi Xiao, Walter Luiz Siqueira, Raquel Mantuaneli Scarel‐Caminaga   +7 more
wiley   +1 more source

A rare overlap: an image of ANCA-associated glomerulonephritis superimposed on membranous nephropathy. [PDF]

J Bras Nefrol
Oliveira AC, Bessa MIV, Silva R.
europepmc   +1 more source

Porphyromonas gingivalis GroEL accelerates abdominal aortic aneurysm formation by matrix metalloproteinase‐2 SUMOylation in vascular smooth muscle cells: A novel finding for the activation of MMP‐2

Molecular Oral Microbiology, EarlyView.
Abstract Infection is a known cause of abdominal aortic aneurysm (AAA), and matrix metalloproteases‐2 (MMP‐2) secreted by vascular smooth muscle cells (SMCs) plays a key role in the structural disruption of the middle layer of the arteries during AAA progression.
Yi‐Wen Lin, Feng‐Yen Lin, Ze‐Hao Lai, Chien‐Sung Tsai, Yi‐Ting Tsai, Yen‐Sung Huang, Chen‐Wei Liu   +6 more
wiley   +1 more source

Membranous Nephropathy

, 2019
Bhadran, Bose,, V., Badve, Sunil, Vivekanand, Jha,, Au, Peh, Chen, David, Johnson,   +4 more
openaire   +4 more sources

Case Report: A case of rituximab for membranous nephropathy secondary to primary Sjogren's syndrome and literature review. [PDF]

Front Immunol
Fu X, Gao F, Zang L, Mao N.
europepmc   +1 more source

Reconsideration of Response Assessment in Obinutuzumab-Treated Membranous Nephropathy. [PDF]

Kidney Int Rep
Atay İ, Eröz E, Heybeli C.
europepmc   +1 more source

Clinical implications of imlifidase interference in antibody screening and transfusion management

Transfusion, EarlyView.
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani, Aiko P. J. de Vries, Arjan Albersen   +2 more
wiley   +1 more source

Rituximab for the treatment of membranous nephropathy in a patient with ankylosing spondylitis: a case report. [PDF]

Front Med (Lausanne)
Zhong R, Su L, Li H, Zhu H, Xiao Z.
europepmc   +1 more source

TREM2+ macrophages accumulate in childhood IgA nephropathy and soluble TREM2 represents a reliable non‐invasive biomarker

Experimental Physiology, EarlyView.
Abstract IgA nephropathy (IgAN) is a common type of primary glomerulonephritis in children. The pathogenesis of childhood IgAN remains unclear, and there is a lack of effective non‐invasive biomarkers for this disease. Single‐cell RNA sequencing was performed in children with IgAN to delineate cellular and molecular compositions, and subcluster ...
Ling Yu, Xuan Gang, Jingjing Wang, Guoping Huang, Qiuyu Li, Weizhong Gu, Haidong Fu, Jianhua Mao   +7 more
wiley   +1 more source